Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy

NCT01472510 is registered in ClinicalTrials.gov with Vitreo-Retinal Associates, PC as lead sponsor.

NCT NCT01472510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01472510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Lead sponsor
Vitreo-Retinal Associates, PC
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema